Gender | Invasive carcinoma of breast Disease length
Item
men with histologically proven invasive breast carcinoma diagnosed since 1990 to 2010.
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Formalin-fixed paraffin-embedded tissue specimen Primary tumor Required | Biopsy | Operative Surgical Procedures
Item
a ffpe tissue sample from the primary tumor (e.g. biopsy or surgery) is mandatory
boolean
C2711483 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0005558 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Part prospective
Item
prospective part:
boolean
C0449719 (UMLS CUI [1,1])
C0023981 (UMLS CUI [1,2])
Gender | Invasive carcinoma of breast | Study Subject Participation Status newly present | Independent of Disease stage | Date of diagnosis Initial | Treatment Initial
Item
all men, with histologically proven invasive breast cancer, newly presenting at the center irrespective of the stage of disease, initial diagnosis date or treatment received.
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2])
C2348568 (UMLS CUI [3,1])
C0750546 (UMLS CUI [3,2])
C0150312 (UMLS CUI [3,3])
C0332291 (UMLS CUI [4,1])
C0699749 (UMLS CUI [4,2])
C2316983 (UMLS CUI [5,1])
C0205265 (UMLS CUI [5,2])
C0087111 (UMLS CUI [6,1])
C0205265 (UMLS CUI [6,2])
Study Subject Participation Status | Retrospective Study | Protection Study
Item
patients cannot be registered in both the retrospective and protective parts of the study
boolean
C2348568 (UMLS CUI [1])
C0035363 (UMLS CUI [2])
C1545588 (UMLS CUI [3,1])
C0947630 (UMLS CUI [3,2])
Study Subject Participation Status newly present | Participation Retrospective Study Excluded
Item
patients who newly present at the center in the 3 months prior to center activation are still eligible as long as they were not previously included in the retrospective part of the study
boolean
C2348568 (UMLS CUI [1,1])
C0750546 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,3])
C0679823 (UMLS CUI [2,1])
C0035363 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
Informed Consent
Item
before patient registration, written informed consent must be obtained according to ich/gcp, and national/local regulations.
boolean
C0021430 (UMLS CUI [1])
Formalin-fixed paraffin-embedded tissue specimen Residual Optional | Tumor tissue sample Frozen Optional | Blood specimen Optional
Item
collection of left-over ffpe and frozen tumor samples as well as blood is optional.
boolean
C2711483 (UMLS CUI [1,1])
C1609982 (UMLS CUI [1,2])
C1518600 (UMLS CUI [1,3])
C0475358 (UMLS CUI [2,1])
C0016701 (UMLS CUI [2,2])
C1518600 (UMLS CUI [2,3])
C0178913 (UMLS CUI [3,1])
C1518600 (UMLS CUI [3,2])
Parts Both
Item
both parts:
boolean
C0449719 (UMLS CUI [1,1])
C1706086 (UMLS CUI [1,2])
Noninfiltrating Intraductal Carcinoma allowed | Condition Invasive cancer Present | Lobular carcinoma in situ of breast allowed
Item
concomitant dcis or lcis are allowed only if invasive cancer is present.
boolean
C0007124 (UMLS CUI [1,1])
C0683607 (UMLS CUI [1,2])
C1705253 (UMLS CUI [2,1])
C0677898 (UMLS CUI [2,2])
C0150312 (UMLS CUI [2,3])
C0279563 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
Age
Item
patients should be 18 years or over at the time of diagnosis.
boolean
C0001779 (UMLS CUI [1])
Disease stage All Acceptable | Early-Stage Breast Carcinoma | Locally advanced breast cancer | Neoplasm Metastasis | Independent of Treatment | Cancer Other Eligible
Item
the study will accept all stages of disease (e.g. early bc, locally advanced and metastatic disease) independent of the treatment received. patients with past or concurrent other malignancies are eligible.
boolean
C0699749 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C1879533 (UMLS CUI [1,3])
C2986665 (UMLS CUI [2])
C3495949 (UMLS CUI [3])
C0027627 (UMLS CUI [4])
C0332291 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C1707251 (UMLS CUI [6,1])
C1548635 (UMLS CUI [6,2])